WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta.

[1]  F. Alkuraya,et al.  Study of autosomal recessive osteogenesis imperfecta in Arabia reveals a novel locus defined by TMEM38B mutation , 2012, Journal of Medical Genetics.

[2]  K. Garcia,et al.  Structural Basis of Wnt Recognition by Frizzled , 2012, Science.

[3]  Jay Shendure,et al.  Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome. , 2012, American journal of human genetics.

[4]  P. Frommolt,et al.  Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. , 2012, American journal of human genetics.

[5]  P. Lapunzina,et al.  Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta , 2012, Human mutation.

[6]  R. Nusse,et al.  Wnt proteins. , 2012, Cold Spring Harbor perspectives in biology.

[7]  B. Dawson,et al.  Mutations in SERPINF1 Cause Osteogenesis Imperfecta Type VI , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  A. Robling,et al.  High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes. , 2011, Bone.

[9]  F. Alkuraya,et al.  Mutations in FKBP10 cause both Bruck syndrome and isolated osteogenesis imperfecta in humans , 2011, American journal of medical genetics. Part A.

[10]  J. Plachy,et al.  Fatty acid modification of Wnt1 and Wnt3a at serine is prerequisite for lipidation at cysteine and is essential for Wnt signalling. , 2011, Cellular signalling.

[11]  P. Byers,et al.  Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes. , 2011, Human molecular genetics.

[12]  A. Hoischen,et al.  Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. , 2011, American journal of human genetics.

[13]  Jeong-Chae Lee,et al.  Wnt/β-catenin signaling enhances osteoblastogenic differentiation from human periodontal ligament fibroblasts , 2010, Molecules and cells.

[14]  P. Lapunzina,et al.  Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. , 2010, American journal of human genetics.

[15]  Lynda F. Bonewald,et al.  Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis , 2010, Molecular and Cellular Biology.

[16]  P. Byers,et al.  Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. , 2010, American journal of human genetics.

[17]  C. Rotimi,et al.  Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. , 2010, The New England journal of medicine.

[18]  P. Byers,et al.  Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. , 2010, American journal of human genetics.

[19]  G. Pals,et al.  PPIB mutations cause severe osteogenesis imperfecta. , 2009, American journal of human genetics.

[20]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[21]  S. Aaronson,et al.  Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells , 2009, The Journal of cell biology.

[22]  P. Kincade,et al.  Wnt-related molecules and signaling pathway equilibrium in hematopoiesis. , 2009, Cell stem cell.

[23]  John J. Mitchell,et al.  CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta , 2008, Human mutation.

[24]  S. Janz,et al.  Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF , 2007, Molecular Cancer.

[25]  C. Tifft,et al.  Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta , 2007, Nature Genetics.

[26]  J. Mulvihill,et al.  Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. , 2006, The New England journal of medicine.

[27]  F. Glorieux,et al.  CRTAP Is Required for Prolyl 3- Hydroxylation and Mutations Cause Recessive Osteogenesis Imperfecta , 2006, Cell.

[28]  Hans Clevers,et al.  Wnt Signaling Controls the Phosphorylation Status of β-Catenin* , 2002, The Journal of Biological Chemistry.

[29]  Richard P Lifton,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[30]  E. Wagner,et al.  Reaching a genetic and molecular understanding of skeletal development. , 2002, Developmental cell.

[31]  Mark L. Johnson,et al.  A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.

[32]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[33]  M. Capecchi,et al.  Swaying is a mutant allele of the proto-oncogene Wnt-1 , 1991, Cell.

[34]  Andrew P. McMahon,et al.  The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain , 1990, Cell.